Thirty-seven carriers (52.1%) had a compromised glucose tolerance, for which ten were treated with tablets (non insulin depending diabetes mellitus) and 20 required insulin treatment (insulin depending diabetes mellitus). The gene discussed is INS; the disease is diabetes mellitus.